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a b s t r a c t
The evolutionarily conserved target of rapamycin (TOR) kinase controls fundamental metabolic processes
to support cell and tissue growth. TOR functions within the context of two distinct complexes, TORC1 and
TORC2. TORC2, with its speciﬁc component Rictor, has been recently implicated in aging and regulation
of growth and metabolism. Here, we identify rict-1/Rictor as a regulator of embryonic development in C.
elegans. The transcription factor skn-1 establishes development of the mesendoderm in embryos, and is
required for cellular homeostasis and longevity in adults. Loss of maternal skn-1 function leads to mis-
speciﬁcation of the mesendodermal precursor and failure to form intestine and pharynx. We found that
genetic inactivation of rict-1 suppressed skn-1-associated lethality by restoring mesendodermal speci-
ﬁcation in skn-1 deﬁcient embryos. Inactivation of other TORC2 but not TORC1 components also partially
rescued skn-1 embryonic lethality. The SGK-1 kinase mediated these functions downstream of rict-1/
TORC2, as a sgk-1 gain-of-function mutant suppressed the rict-1 mutant phenotype. These data indicate
that TORC2 and SGK-1 antagonize SKN-1 during embryonic development.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The mammalian target of rapamycin (TOR) kinase is highly
conserved in eukaryotes and integrates nutrient and anabolic signals
to promote growth (Laplante and Sabatini, 2009; Wullschleger et al.,
2006; Zoncu et al., 2011). TOR participates in two biochemically and
functionally distinct kinase complexes, TORC1 and TORC2. TORC1
consists of TOR, Raptor (regulatory associated protein of mTOR), and
LST8 (lethal with Sec13 protein8). Growth signals, nutrients, oxygen,
and energy levels have been shown to activate TORC1. TORC1
regulates a set of well-characterized substrates to promote growth-
related processes including protein synthesis, ribosome biosynthesis,
and transcription, and to inhibit autophagy (reviewed in Loewith and
Hall, 2011).
TORC2 includes the conserved proteins Rictor (rapamycin-
insensitive companion of TOR), LST8, and Sin1 (stress activated
protein kinase interacting protein 1), along with TOR. In contrast
to TORC1, the upstream inputs and downstream effectors of TORC2
are poorly understood. Recent studies demonstrated that growth
signals and association with ribosomes activate TORC2 (Oh et al.,
2010; Zinzalla et al., 2011). TORC2 phosphorylates AGC kinases
such as Akt and SGK (serum- and glucocorticoid-induced protein
kinase) to activate downstream signaling (Zoncu et al., 2011).
Phosphorylation of Akt at the hydrophobic site by TORC2 is
important for its functions in cellular processes including cell
proliferation and survival (Hresko and Mueckler, 2005; Sarbassov
et al., 2005). Similarly to Akt, SGK1 is phosphorylated at its
hydrophobic motif site by TORC2, which thereby regulates its
activity (Garcia-Martinez and Alessi, 2008).
Rictor is required for TORC2 integrity and substrate speciﬁcity.
Previous studies have established a conserved role for TORC2 in cell
growth and metabolism (Cybulski et al., 2009; Hietakangas and
Cohen, 2007; Shiota et al., 2006). Knockdown of Rictor/rict-1 in
Caenorhabditis elegans resulted in an overall reduction of body size,
developmental delay, and defects in fat metabolism (Jones et al.,
2009; Soukas et al., 2009). Interestingly, these effects of rict-1
signaling were largely mediated through SGK-1, rather than AKT-1/2
in C. elegans. Moreover, genetic studies in C. elegans have shown
that inhibition of rict-1 during adulthood confers longevity (Robida-
Stubbs et al., 2012). Importantly, the transcription factor skn-1 was
required for lifespan to be increased by rict-1 knockdown. SKN-1
and its mammalian ortholog Nrf have conserved functions in stress
detoxiﬁcation, and contribute to longevity (Sykiotis and Bohmann,
2010). SKN-1/Nrf orchestrates gene expression programs involved
in stress resistance, longevity, protein homeostasis, and metabolism
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Fig. 1. Loss of rict-1 rescues lethality in skn-1 deﬁcient embryos and acts in a pathway with sgk-1. (A) skn-1 embryonic lethality is suppressed by mutation of rict-1. RNAi
feeding was used to inactivate skn-1 function in wild-type and rict-1mutants starting from L1. Their total progeny and the portion that survived and progressed past the ﬁrst
larval stage (L1) was scored. The progeny of n419 adult hermaphrodites for each condition was analyzed. Error bars indicate SEM. ***po0.0001 versus wild-type on skn-1
(RNAi). See also Table 1. (B) Quantiﬁcation of the fraction of survivors of rict-1;skn-1 double mutants. rict-1(mg451);skn-1(zu67) and skn-1(zu67) mutants were grown on
OP50 and the fraction of embryos that survived beyond L1 was counted. n439 for each strain. Error bars, SEM. ***po0.0001 versus skn-1(zu67). See also Table 2. (C) sgk-1
mutants suppress lethality of skn-1 deﬁcient embryos. RNAi feeding starting from L1 in wild-type and sgk-1(ok538) mutants. Quantiﬁcation of larval survival per total
progeny. n445 for each strain. Error bars indicate SEM. ***po0.0001 compared to skn-1(RNAi). See also Table 1. (D) Quantiﬁcation of larval survival of wild-type, rict-1
(mg451), sgk-1(ok538), and rict-1(mg451);sgk-1(ok538) fed with skn-1(RNAi). n418 for each strain. Error bars indicate SEM. ns, not signiﬁcant. See also Table 1. (E) sgk-1(ft15)
gain-of-function mutants suppress the viability of rict-1;skn-1(RNAi) embryos. Quantiﬁcation of the fraction of survivors of wild-type, rict-1(mg451), sgk-1(ft15), and rict-1
(mg451);sgk-1(ft15) fed with skn-1(RNAi). n420 for each strain. Error bars indicate SEM. ***po0.0001. See also Table 1.
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(Oliveira et al., 2009; Paek et al., 2012; Wang et al., 2010). The AKT
and SGK-1 kinases phosphorylate SKN-1 and thereby prevent its
accumulation in intestinal nuclei and inhibit its functions (Tullet
et al., 2008).
SKN-1 was originally identiﬁed as an essential regulator of
mesendodermal development during the earliest stages of C. elegans
embryogenesis (Bowerman et al., 1992). Maternally expressed SKN-1
speciﬁes the fate of the EMS blastomere. The E cell deﬁnes the
endoderm comprising the intestine, while the MS cell gives rise to
the mesoderm including the posterior portion of the pharynx, body
muscle cells, and coelomocytes (for review see Maduro, 2010). Loss of
skn-1 leads to a complete lack of MS-derived tissues and to most, but
not all, embryos also lacking intestinal cells (Bowerman et al., 1992,
1993). SKN-1 directly induces expression of the transcription factors
MED-1 and MED-2, which are required for mesendodermal differ-
entiation of the EMS lineage (Coroian et al., 2006; Maduro et al.,
2001). In MS, the MEDs activate the T-box transcription factor tbx-35
and initiate a gene network for mesodermal speciﬁcation (Broitman-
Maduro et al., 2006). Speciﬁcation of the E fate results from activation
of two GATA factor-encoding genes, end-1 and end-3, by the MEDs
and SKN-1 (Maduro et al., 2005; Owraghi et al., 2010; Zhu et al.,
1997). These pathways ﬁnally converge on the activation of the GATA
factor elt-2, which is essential for E lineage development and
maintenance (Fukushige et al., 1999).
The regulatory cascade initiated by SKN-1 collaborates with the
Wnt/β-catenin asymmetry pathway to distinguish MS and E
identity. EMS receives an induction signal from its posterior sister
P2 that results in differential localization and activity of POP-1, a
TCF/Lef-related factor within MS and E. In the MS blastomere, POP-
1 represses the endoderm-speciﬁc gene program allowing meso-
derm development to occur. Inside the E cell, this repression is
relieved and POP-1 is converted to an activator of the endoderm
gene expression network (Lin et al., 1995; Maduro and Rothman,
2002; Rocheleau et al., 1997; Thorpe et al., 1997).
Given that SKN-1 seemed to be required for effects of TORC2 on
longevity, we considered whether TORC2 might inﬂuence SKN-1
functions more broadly. Here, we deﬁne a new function for C.
elegans TORC2 during early embryonic stages. We show that rict-1
mutation decreased the embryonic lethality associated with loss of
skn-1 function by allowing mesendodermal development to be re-
established in a proportion of skn-1 deﬁcient embryos. A gain-of-
function mutation in sgk-1 suppressed these rict-1 developmental
effects, indicating that sgk-1 is a primary effector of rict-1 activity
in this context. In contrast to TORC2, TORC1 did not inﬂuence SKN-
1 activity in the embryo. Our results deﬁne TORC2-SGK-1 as a
pathway that may broadly inﬂuence SKN-1 functions.
Results
Loss of rict-1 rescues lethality of skn-1 deﬁcient embryos
The transcription factor SKN-1 is well established as an initiator of
mesendodermal development in embryos, and controls oxidative
stress response. Since TORC2 has been recently implicated in the
regulation of SKN-1 dependent longevity, we wondered if it interferes
with SKN-1 functions more generally and might be involved in
embryonic development. Rictor (RICT-1) is an essential component
of TORC2. We initiated our study by analyzing the effects of rict-1
mutation on skn-1-dependent developmental processes. The rict-1
allelesmg451 and ft7 contain early stop mutations, and are likely to be
strong loss-of-function and null alleles, respectively (Jones et al., 2009;
Soukas et al., 2009). Embryos from skn-1 deﬁcient mothers undergo
developmental arrest, lack pharynx and endoderm, and die
(Bowerman et al., 1992). First, we used RNAi feeding to inactivate
maternal skn-1 function and to sensitize our ability to detect genetic
interactions. We scored the portion of the skn-1(RNAi) progeny that
hatched and progressed past the ﬁrst larval stage (L1). Consistent
with the crucial role of skn-1 during development, skn-1(RNAi)
resulted in 0.4% viable embryos. Surprisingly, we found that
combining skn-1(RNAi) with mutational rict-1 inactivation strongly
increased the viability of the progeny: 8.2 and 14.1% of eggs
Table 1
Loss of rict-1 rescues lethality in skn-1 deﬁcient embryos and acts in a pathway with sgk-1. Corresponds to Fig. 1A, C–E. RNAi feeding was used to inactivate skn-1 function in
the indicated wild-type and mutant strains starting from L1. Their total progeny and the portion that survived and progressed past the ﬁrst larval stage (L1) was scored. N
represents the number of adult hermaphrodites used for analysis of their progeny.
Strain RNAi n
(Adult worms)
Mean number
of Eggs7SEM
% Survival7SEM P value versus
control
Figure
N2 skn-1 20 23778 0.470.1 1A
rict-1(mg451) skn-1 19 12073 14.171.1 o0.0001a 1A
rict-1(ft7) skn-1 19 9073 8.271.3 o0.0001a 1A
N2 skn-1 45 25674 0.370.1 1C
sgk-1(ok538) skn-1 48 12273 10.771.2 o0.0001a 1C
N2 skn-1 20 24576 0.1 1D
rict-1(mg451) skn-1 20 14172 9.370.8 o0.0001a 1D
sgk-1(ok538) skn-1 18 13974 6.870.5 o0.0001a 1D
rict-1(mg451);sgk-1(ok538) skn-1 19 14973 7.870.6 nsb, nsc, o0.0001a 1D
N2 skn-1 20 238712 0.370.1 1E
rict-1(mg451) skn-1 24 10976 11.571.9 o0.0001a 1E
sgk-1(ft15) skn-1 20 203718 0.270.1 nsa 1E
rict-1(mg451);sgk-1(ft15) skn-1 24 15475 1.770.2 o0.0001b 1E
sgk-1(ft15) control 5 243711 100
rict-1(mg451);sgk-1(ft15) control 5 122710 100
N2 skn-1 10 27576 0.670.1
akt-1(ok525) skn-1 10 19878 0.670.2 nsa
akt-2(ok393) skn-1 10 210714 0.570.1 nsa
rict-1(mg451) skn-1 10 11376 8.870.8 o0.0001a
ns, not signiﬁcant. SEM, standard error of the mean.
a p value was calculated versus N2 skn-1(RNAi).
b p value was calculated versus rict-1(mg451), skn-1(RNAi).
c p value was calculated versus sgk-1(ok538):skn-1(RNAi).
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produced by rict-1(ft7) and rict-1(mg451) mutants, respectively, fed
with skn-1(RNAi) give rise to viable offspring (Fig. 1A and Table 1).
Here, rict-1(mg451) and rict-1(ft7) survival was not statistically
different. We also injected dsRNA corresponding to the skn-1 gene
into the gonad of rict-1(mg451) mutants and wild-type worms and
again observed that about 6% of rict-1(mg451);skn-1(RNAi) embryos
hatched while 100% of skn-1(RNAi) embryos arrested development
(data not shown). To test whether rict-1 speciﬁcally inﬂuenced skn-
1 function and rule out that inactivation of rict-1 interferes with
sensitivity to dsRNA per se, we tested two embryonic-lethal genes
that to our knowledge are not defective in functions related to skn-
1: let-423 and cdk-2. The complete embryonic lethality that was
associated with RNAi-mediated knockdown of these genes was not
altered in rict-1 mutants (data not shown).
Next, we generated rict-1;skn-1 double mutants and analyzed
the fraction of survivors. The skn-1 mutations zu67 and zu135
introduce premature stop codons and are predicted to be
strong loss-of-function alleles based on the removal of the con-
served DNA binding domain (Supplementary Fig. S1). Adult
hermaphrodites homozygous for mutations in skn-1 produced no
viable offspring, while double knockout of rict-1(mg451) and skn-1
(zu67) signiﬁcantly suppressed embryonic lethality. 3.9% of
embryos produced by rict-1;skn-1 double mutants were viable
and hatched (Fig. 1B). This ﬁnding was conﬁrmed by several alleles
for rict-1 and skn-1 (Table 2). Thus, rict-1 inactivation suppressed
the embryonic lethality caused by skn-1 deﬁciency. Interestingly,
rict-1;skn-1 mutant embryos that hatched developed into repro-
ductive adults. They did not show obvious morphological defects
and even produced progeny, although they grew slower and were
smaller in body size than was characteristic of rict-1 mutants
(Supplementary Fig. S2). The observation that the embryonic
lethality associated with skn-1 can be partially suppressed by
inhibition of rict-1 suggests that rict-1 and TORC2 antagonize skn-1
functions during development.
rict-1 acts in a pathway with sgk-1 to effect skn-1 embryo survival
TORC2 has been reported to activate several AGC family kinases,
including AKT and the serum- and glucocorticoid-induced kinase
SGK (Garcia-Martinez and Alessi, 2008; Sarbassov et al., 2005).
To investigate the mechanisms through which rict-1 regulates
embryonic development, we ﬁrst focused on Akt signaling. We
analyzed the effect of akt-1 and akt-2 knockdown on skn-1()
embryo survival. However, inactivation of akt-1 or akt-2 did not
restore viability of skn-1(RNAi) embryos ((0.6% viable embryos in akt-
1(ok525);skn-1(RNAi) and 0.5% in akt-2(ok393);skn-1(RNAi) com-
pared to 8.8% in rict-1(mg451);skn-1(RNAi)) (Table 1). We conclude
that the increased viability of rict-1;skn-1 deﬁcient embryos is not a
consequence of compromised AKT signaling.
In C. elegans, rict-1 regulates growth, larval development, and
metabolism largely through sgk-1 (Jones et al., 2009; Soukas et al.,
2009). To evaluate the possible role of sgk-1 in embryonic devel-
opment we analyzed the effect of sgk-1 knockdown on skn-1()
embryo survival. The sgk-1(ok538) deletion removes most of the
region encoding the kinase domain, and is likely a null allele
(Hertweck et al., 2004). We found that sgk-1 mutants rescued the
lethality of skn-1 deﬁcient embryos: 10.7% of sgk-1(ok538);skn-1
(RNAi) embryos were viable compared to 0.3% skn-1(RNAi) (Fig. 1C
and Table 1). Moreover, skn-1(zu67);sgk-1(ok538) double mutants
produced 1.8% viable embryos, while all embryos from skn-1(zu67)
mutant underwent developmental arrest and died (Table 2). Hence,
loss of sgk-1 function mimics rict-1, in that it partially rescued skn-1
() embryonic lethality, suggesting a genetic relationship.
To assess whether rict-1 and sgk-1 deﬁne a genetic pathway in
the embryo, we created rict-1(mg451);sgk-1(ok538) double
mutants. 7.8% of rict-1;sgk-1 double mutants fed with skn-1(RNAi)
gave viable progeny (Fig. 1D and Table 1). There was no signiﬁcant
difference in fraction of survivors compared to either single
mutant (9.3% for rict-1(mg451);skn-1(RNAi) and 6.8% for sgk-1
(ok538);skn-1(RNAi)). These results suggest that rict-1 and sgk-1
act in the same pathway.
This hypothesis was further strengthened by the analysis of a
sgk-1 gain-of-function mutant. If sgk-1 acts downstream of rict-1
to regulate skn-1 embryonic development then a gain-of-function
mutation in sgk-1 should suppress the viability of rict-1();skn-1
(). The sgk-1(ft15) gain-of-function mutant has been previously
shown to suppress many phenotypes associated with rict-1 (Jones
et al., 2009). We indeed found that sgk-1(ft15) greatly suppressed
the fraction of viable embryos of rict-1;skn-1(RNAi), 1.7% of rict-1
(mg451);sgk-1(ft15);skn-1(RNAi) progeny were viable, compared to
11.5% in rict-1(mg451);skn-1(RNAi) (Fig. 1E and Table 1). sgk-1(ft15)
mutants displayed normal development and broodsize and did not
inﬂuence skn-1() embryo survival. Taken together, these obser-
vations indicate that rict-1 functions through sgk-1 to regulate
embryonic development mediated by skn-1.
TORC1 inhibition cannot suppress skn-1 embryonic lethality
TOR exists in two distinct complexes: association with RICT-1/
CeRictor deﬁnes TORC2, while DAF-15/CeRaptor is the essential
Table 2
Quantiﬁcation of the fraction of survivors of rict-1;skn-1 and skn-1;sgk-1 double mutants. Indicated strains were grown on OP50 and the
fraction of embryos that survived beyond L1 was counted.
Strain n
(Adult worms)
Mean number
of Eggs7SEM
% Survival
7SEM
P value versus
control
Figure
N2 5 272712 100
rict-1(mg451) 5 11674 100
skn-1(zu67) 40 232710 0 1B
rict-1(mg451);skn-1(zu67) 39 11974 3.970.3 o0.0001a 1B
skn-1(zu135) 24 272713 0
rict-1(mg451);skn-1(zu135) 19 155713 2.470.7 o0.0001b
rict-1(ft7) 5 9172 100
skn-1(zu67) 10 27376 0
rict-1(ft7);skn-1(zu67) 13 15477 3.070.5 o0.0001a
sgk-1(ok538) 5 13974 100
skn-1(zu67) 23 25979 0
skn-1(zu67);sgk-1(ok538) 24 14576 1.870.2 o0.0001a
a p value was calculated versus skn-1(zu67).
b p value was calculated versus skn-1(zu135).
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component of TORC1. We wondered whether the effect of rict-1
inhibition on embryonic development might be phenocopied
by components of TORC1.
The rheb-1 GTPase is the key activator of TORC1 (Honjoh et al.,
2009; Long et al., 2005; Yang and Guan, 2007). We found that
knockdown of rheb-1 by RNAi did not suppress lethality of skn-1
(zu67) mutant embryos. Although rheb-1(RNAi) efﬁciently reduced
the RHEB-1 levels as evidenced by greatly abolished expression of
a rheb-1::GFP reporter construct (data not shown), fewer than 0.4%
of skn-1(zu67);rheb-1(RNAi) embryos were viable, while sgk-1
(RNAi) signiﬁcantly rescued the lethality of skn-1 deﬁcient
embryos (Fig. 2A and Table 3). Likewise, simultaneous RNAi-
mediated knockdown of rheb-1 and skn-1 did not increase the
fraction of viable embryos as compared to skn-1(RNAi) alone
(Table 3). daf-15 encodes the C. elegans homolog of Raptor, and is
essential for TORC1 activity. We found that knockdown of daf-15
failed to rescue embryonic lethality of skn-1 mutants (Fig. 2A),
while daf-15(RNAi) strongly reduced daf-15 activity and caused a
dauer-like larval arrest (data not shown) (Jia et al., 2004). Con-
sistently, combined inhibition of daf-15 and skn-1 by RNAi did not
promote embryonic viability (Table 3). The TOR kinase let-363 is at
the center of both TOR complexes and therefore affects function of
TORC1 and TORC2. As would be predicted, RNAi against let-363
suppressed the lethality of skn-1mutants. 1.1% of eggs produced by
skn-1(zu67);let-363(RNAi) gave rise to viable offspring compared
to 0% of skn-1(zu67) (Fig. 2A and Table 3).
TORC1 plays an essential role during development. Consistent with
published ﬁndings, inactivation of TORC1-speciﬁc genes by RNAi
starting from L1 caused a dauer-like larval arrest of the F1 progeny
(Jia et al., 2004; Long et al., 2002). Similarly, homozygous TORC1
mutants arrest larval development. To exclude that complete TORC1
inactivation might mask a rescue effect on skn-1 by interfering with
larval development, we analyzed heterozygous TORC1 component
mutants. Previous studies have shown that heterozygous daf-15
mutants display no obvious developmental defects but show signiﬁ-
cantly extended lifespan, indicating that loss of gene dose might
decrease daf-15 activity enough to be effective (Jia et al., 2004).
Nevertheless, we found that daf-15(m81) heterozygousity did not
suppress skn-1(RNAi) embryonic lethality (Supplementary Fig. S3
and Table 3). Consistent with the results on let-363(RNAi), hetero-
zygous let-363mutants slightly rescued the lethality of skn-1 deﬁcient
embryos, 1.9% of let-363(h111)/þ;skn-1(RNAi) embryos were viable
compared to 0.2% skn-1(RNAi) (Supplementary Fig. S3 and Table 3).
Taken together these results indicate that inhibition of TORC1-
speciﬁc components rheb-1 and daf-15/Raptor cannot suppress
lethality of skn-1 deﬁcient embryos, suggesting that TORC1 does
not inﬂuence skn-1-mediated regulation of embryonic develop-
ment. Since inhibition of the TOR kinase let-363 would eliminate
TORC1 as well as TORC2 knockdown of let-363/TOR might at least
partially promotes viability of skn-1 embryos.
Inhibition of TORC2 prevents skn-1 embryonic lethality
The TORC2 complex includes the LST8 and Sin1 proteins, in
addition to Rictor and TOR. To investigate further whether TORC2
regulates skn-1 embryonic functions, we examined the role of
these two proteins. sinh-1 encodes the C. elegans ortholog of
mammalian Sin1, which plays a key role in Akt phosphorylation
and signaling (Yang et al., 2006). Inactivation of sinh-1 by RNAi
only slightly rescued embryonic lethality of skn-1 mutants (Fig. 2B
and Table 3). However, combined knockdown of sinh-1 and skn-1
by RNAi signiﬁcantly suppressed skn-1 embryonic lethality, 4.1% of
sinh-1(RNAi);skn-1(RNAi) embryos were viable compared to 0.3%
of skn-1(RNAi) (Table 3).
Next, we analyzed the effect of lst-8. LST8 is present in both
TOR complexes, but recent data indicate that mLST8 is critical for
TORC2 function (Guertin et al., 2006; Wang et al., 2012). We found
that loss of lst-8 activity by RNAi resulted in increased fraction of
12.3% viable skn-1(zu67) embryos (Fig. 2B and Table 3). Surpris-
ingly the effect of lst-8(RNAi) on skn-1() viability was signiﬁ-
cantly stronger than rict-1 or sgk-1.
Taken together, inhibition of TORC2-speciﬁc components, rict-
1, lst-8, and sinh-1 can partially restore embryonic viability of skn-
1 deﬁcient embryos. These ﬁndings indicate new physiological
roles of TORC2 in the regulation of embryonic development
mediated by skn-1.
Inactivation of rict-1 promotes mesodermal speciﬁcation
SKN-1 activates a complex gene network that speciﬁes the
development of endoderm (intestine) and part of the mesoderm
(including pharynx and body muscle). Embryos from skn-1 deﬁ-
cient mothers arrest development and fail completely to specify
the pharynx, while endoderm is absent in approximately 70% of
the embryos (Bowerman et al., 1992, 1993). In the EMS blastomere
SKN-1 directly activates expression of the two transcription
factors, med-1 and med-2 (Coroian et al., 2006; Maduro et al.,
2001). To promote speciﬁcation of the endoderm, SKN-1 and the
MEDs initiate a short signaling cascade by activating the GATA
factor genes end-1 and end-3. Either END transcription factor can
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Fig. 2. TORC2 but not TORC1 can suppress lethality of skn-1 deﬁcient embryos.
(A) Inhibition of TORC1 components cannot suppress skn-1() embryonic lethality.
skn-1(zu67) mutants were fed with daf-15/CeRaptor(RNAi), rheb-1(RNAi), let-363/
CeTOR(RNAi), and sgk-1(RNAi). Quantiﬁcation of the fraction of survivors. n420
per each condition. Error bars indicate SEM. *po0.05, ***po0.001. ns, not
signiﬁcant. See also Table 3. (B) Inhibition of TORC2 promotes skn-1() embryonic
viability. Quantiﬁcation of survival of skn-1(zu67) mutant embryo fed with rict-1
(RNAi), sinh-1(RNAi), lst-8(RNAi), and sgk-1(RNAi). n420 per each condition. Error
bars indicate SEM. *po0.05, ***po0.001. See also Table 3.
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then activate the GATA factor elt-2, which is a key regulator of
intestinal development (Fukushige et al., 1998; Goszczynski and
McGhee, 2005; Maduro et al., 2007). The fate of the mesodermal
precursor cell MS is speciﬁed primarily by activation of the T-box
transcription factor tbx-35 by the MEDs (Broitman-Maduro et al.,
2006, 2009). TBX-35 then regulates tissue-speciﬁc factors for
pharynx and muscle development (Fig. 3A).
Given the impact of TORC2 on regulation of skn-1 embryonic
development, we wondered whether rict-1 interferes with the
gene network for mesendodermal speciﬁcation. First, we assessed
the production of MS-derived cell types. The MS blastomere
generates diverse cell types, including pharyngeal cells. ceh-22 is
expressed exclusively in the pharyngeal muscles, and together
with pha-4 it is the earliest known marker of pharyngeal muscle
differentiation (Okkema and Fire, 1994). To score the production of
pharyngeal muscle cells we used a chromosomally integrated ceh-
22::GFP reporter. As expected, skn-1 deﬁcient embryos did not
show any signiﬁcant expression of ceh-22::GFP. In contrast, we
found that 46% of rict-1(mg451);skn-1(RNAi) embryos produced
pharyngeal muscle cells (Fig. 3B, D and F). rict-1 mutants alone
showed normal pharynx development and ceh-22::GFP expression
similar to wild-type (Fig. 3B, C and E). Interestingly, three times
more rict-1;skn-1 embryos displayed induction of pharyngeal
development (46%) while only one third completed development,
hatched and were viable. The majority of rict-1;skn-1 embryos
arrested at varying stages. Of note, we did not detect ectopic ceh-
22::GFP expression in rict-1;skn-1 embryos. Hence, inactivation of
rict-1 seems to restore pharyngeal speciﬁcation to a greater extent
than is apparent based upon scoring for viability.
E-derived tissues are made in rict-1;skn-1 Embryos
The principal target of the E-speciﬁcation gene network initiated
by SKN-1 is the transcription factor elt-2 (Fukushige et al., 1998). ELT-2
is required for embryonic gut development, and maintenance of the
gut throughout larval development and adulthood (Fukushige et al.,
1998; McGhee et al., 2007, 2009). To assess endoderm development,
we introduced a chromosomally integrated elt-2::GFP reporter into
rict-1 mutants. Expression of elt-2::GFP was detected in 55% of rict-1
(mg451);skn-1(RNAi) embryos, while inactivation of skn-1 alone
resulted in 29% of embryos with intestinal cells (Fig. 4B, D, and E).
rict-1 mutants expressed elt-2::GFP in almost 100% of embryos
similarly to wild-type (Fig. 4A, C, and E). This result suggests that
inhibition of rict-1 partially rescues impaired gut formation in skn-1
deﬁcient embryos. The observation that a fraction of skn-1 deﬁcient
embryos still generates intestinal cells is in line with the literature
(Bowerman et al., 1992; Maduro et al., 2007) and might be the
consequence of endoderm speciﬁcation from a number of parallel
activities.
Next, we wondered if the induction of endoderm development by
loss of rict-1 might reﬂect changes in the number of gut cells. We
therefore quantiﬁed the number of gut cells using the integrated elt-
2::GFP reporter, as it has been performed in previous studies (Kostic
and Roy, 2002; Maduro et al., 2007). The E cell normally divides 4–5
times to produce 20 intestinal cells by the end of embryogenesis
(Sulston et al., 1983). As expected, wild-type embryos produced an
average of 20 elt-2 expressing cells with little variation (Supplemen-
tary Fig. S4). We found that rict-1 mutant embryos generate a nearly
identical mean number of endodermal cells as detected in wild-type
Table 3
TORC2 but not TORC1 can suppress lethality of skn-1 deﬁcient embryos. Indicated strains were fed with RNAi and the fraction of embryos that survived beyond L1 was
counted.
Strain RNAi n (Adult worms) Mean number of Eggs7SEM % Survival7SEM P value versus control Figure
skn-1(zu67) control 34 211710 0 2A
skn-1(zu67) let-363 42 6575 1.170.3 o0.05a 2A
skn-1(zu67) daf-15 33 13279 0.0570.04 nsa 2A
skn-1(zu67) rheb-1 23 118711 0.470.2 nsa 2A
skn-1(zu67) sgk-1 35 10076 3.970.5 o0.001a 2A
skn-1(zu67) control 38 20379 0 2B
skn-1(zu67) sinh-1 39 15276 0.870.1 o0.05a 2B
skn-1(zu67) lst-8 35 5874 12.371.5 o0.001a 2B
skn-1(zu67) rict-1 20 8976 5.271.6 o0.001a 2B
skn-1(zu67) sgk-1 40 9875 4.670.6 o0.001a 2B
N2 skn-1 29 22778 0.270.1 Suppl.3
let-363(h111)/þ skn-1 30 166712 1.970.3 o0.05c Suppl.3
daf-15(m81)/þ skn-1 30 20778 0.770.2 nsc Suppl.3
rict-1(mg451) skn-1 29 8773 10.571.0 o0.001c Suppl.3
Strain Combined RNAi n (Adult worms) Mean number of Eggs7SEM % Survival7SEM P value versus control
rrf-3(pk1426) control;skn-1 30 6873 0.270.1
rrf-3(pk1426) rheb-1;skn-1 21 5374 0.170.1 nsb
rrf-3(pk1426) rict-1;skn-1 29 6575 3.270.9 o0.001b
rrf-3(pk1426) sgk-1;skn-1 29 5374 9.071.1 o0.001b
rrf-3(pk1426) control;skn-1 39 7273 0.470.2
rrf-3(pk1426) daf-15;skn-1 36 4873 0.570.2 nsb
rrf-3(pk1426) rict-1;skn-1 39 7175 2.770.7 o0.001b
rrf-3(pk1426) sgk-1;skn-1 39 5374 14.072.3 o0.001b
rrf-3(pk1426) control;skn-1 28 7073 0.370.1
rrf-3(pk1426) sinh-1;skn-1 29 6873 4.170.8 o0.001b
rrf-3(pk1426) rict-1;skn-1 28 6574 3.770.8 o0.001b
rrf-3(pk1426) sgk-1;skn-1 19 6873 8.571.4 o0.001b
ns, not signiﬁcant.
a p value was calculated versus skn-1(zu67) on control(RNAi).
b p values wase calculated versus rrf-3(pk1426) on control;skn-1(RNAi).
c p values was calculated versus N2 on skn-1(RNAi).
V. Ruf et al. / Developmental Biology 384 (2013) 214–227 219
Fig. 3. Rescue of defective mesodermal development in skn-1 embryos by inactivation of rict-1. (A) The C. elegans gene network for speciﬁcation of mesoderm and endoderm
through SKN-1 and the Wnt-effector POP-1, modiﬁed from Maduro (2009). (B) Embryos lacking rict-1 and skn-1 function make MS-type pharynx. Wild-type and rict-1
(mg451) mutants bearing the integrated cuIs1[ceh-22::GFP] marker were fed with control(RNAi) or skn-1(RNAi) as indicated. Bars show percentage of terminally arrested
embryos positive for ceh-22::GFP signal. Error bars, SEM. n, number of embryos analyzed. Mann–Whitney rank sum test. ***po0.001. (C–F) Paired DIC (left) and ceh-22::GFP-
ﬂuorescence images (right) of representative embryos. Scale bar represents 20 μm. (C) In wild-type embryos the ceh-22::GFP marker shows broad induction of mesodermal
tissue. (D) skn-1(RNAi) embryos arrest development and completely lack ceh-22::GFP expression. (E) In rict-1(mg451)mutants ceh-22::GFP expression is similar to wild-type.
(F) rict-1(mg451);skn-1(RNAi) embryos show pharynx speciﬁcation evident by ceh-22::GFP expression.
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(18.970.2), although with a slightly higher variance. The increased
variance is likely to have resulted from the delayed development in
rict-1 mutants (Soukas et al., 2009) rather than differences in gut cell
number. In rict-1 mutant embryos we did not detect elt-2::GFP
expression in more than 20 cells. Among skn-1(RNAi) embryos that
still made endoderm, the average number of gut cells was dramatically
reduced to 8.970.5, with a range of 2–18 gut cells. rict-1(mg451);skn-
1(RNAi) embryos showed a higher mean number of gut cells
(15.170.5, range of 4–20) and a higher portion of embryos (10%)
with a normal number of gut cells compared to skn-1(RNAi) (Supple-
mentary Fig. S4). We conclude therefore that loss of rict-1 function can
promote normal development of the endoderm in skn-1 embryos.
Loss of rict-1 induces med-1 in embryos lacking skn-1
Our ﬁnding that E- and MS-speciﬁc genes are expressed
in rict-1;skn-1 embryos supports the hypothesis that the
canonical pathway for E and MS speciﬁcations is active. Two
transcription factors, med-1 and med-2, are immediately acti-
vated by SKN-1 in EMS and essential for endomesodermal
development (Maduro et al., 2001, 2007). To further analyze
whether intestinal and pharyngeal cells made in rict-1;skn-1
embryos result from normal EMS speciﬁcation, we introduced
the translational fusion reporter med-1::GFP. In wild-type
embryos, med-1::GFP expression is ﬁrst detectable in EMS at
the six-cell stage, and this expression is transient and becomes
weaker in E and MS descendents (Maduro et al., 2001, 2007).
Inactivation of skn-1(RNAi) alone resulted in nearly complete
abrogation of med-1 expression (0.8%) while expression of
med-1::GFP was observed in 9.7% of rict-1(mg451);skn-1(RNAi)
embryos (Fig. 5). Together, these results show that inactivation
of rict-1 induces mesendodermal speciﬁcation in skn-1 deﬁ-
cient embryos involving activation of the canonical genetic
network including med-1.
Fig. 4. Inactivation of rict-1 promotes endoderm development in skn-1 deﬁcient embryos. (A–E) Wild-type and rict-1(mg451) mutants carrying the integrated marker wIs84
[elt-2::NLS::GFP] for intestinal differentiation were fed with control(RNAi) or skn-1(RNAi) as indicated. Paired DIC (left panel) and ﬂuorescence images (right panel) of
embryos expressing elt-2::GFP. Scale bar represents 20 μm. (A) Expression of the elt-2::GFP in the developing gut of wild-type embryos. (B) A large fraction of skn-1(RNAi)
embryos fails to express elt-2::GFP and lacks endoderm. (C) In rict-1(mg451)mutants elt-2::GFP expression does not differ fromwild-type. (D) Inactivation of rict-1(mg451) in
skn-1(RNAi) embryos induces elt-2::GFP expression. (E) Quantiﬁcation of elt-2::GFP positive embryos from A-D. Signiﬁcantly more rict-1 mutants fed with skn-1(RNAi)
develop elt-2::GFP positive gut cells compared to skn-1(RNAi). Mann–Whitney rank sum test, po0.001. Error bars, SEM. n, number of embryos analyzed.
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sknr-1 cannot compensate for loss of skn-1 function in the embryo
We have established above that TORC2 inhibits SKN-1 func-
tions in the embryo. The simplest explanation is that TORC2 acts
on SKN-1 itself, but this would require that residual SKN-1
function be present in the skn-1 mutants we analyzed. Alterna-
tively, rict-1 might affect processes in parallel to or downstream of
SKN-1. First, we evaluated the possibility of residual SKN-1
functions in skn-1(zu67) mutants. Low levels of residual SKN-1
protein might derive from perdurance of the maternal gene
product in the skn-1 (/) animal, or from read-through. rict-1
(mg451);skn-1(zu67) homozygous animals generated about 4%
viable embryos (Fig. 1B and Table 2). These “rescued” offspring
themselves produced viable rescued offspring at a similar rate (not
shown), arguing against perdurance of maternal SKN-1. Supposing
that SKN-1 still bears residual function in skn-1 mutants, we
hypothesized that knockdown of skn-1 by RNAi might suppress
rescue of lethality in rict-1;skn-1 mutants. Using skn-1(RNAi), the
fraction of survivors in rict-1(mg451);skn-1(zu67) was reduced to
2.8%, compared to 5.2% survivors in rict-1;skn-1;control(RNAi)
(Table 4). Hence, residual SKN-1 function might at least partially
contribute to the viability of rict-1;skn-1 embryos.
We considered whether TORC2 and SGK-1 might regulate skn-1
transcription, providing a possible mechanism for restoration of
viability. When we performed quantitative PCR to measure endo-
genous amounts of skn-1 mRNA, we found that skn-1 expression
was not changed in rict-1 and sgk-1 mutants compared to wild-
type (Supplementary Fig. S5). The levels of skn-1 mRNA decreased
in skn-1(zu67) and skn-1(tm3411) mutants consistent with a
previous study (Tullet et al., 2008), and we observed similar skn-
1 expression in rict-1;skn-1 double mutants. Hence, rict-1 and sgk-
1 do not affect SKN-1 functions by modulating the abundance of
skn-1 transcription.
We next investigated whether increased SKN-1 protein stability
might inﬂuence rict-1;skn-1 embryonic viability. It was reported
previously that WDR-23 represses SKN-1 activity by targeting SKN-1
Fig. 5. Loss of rict-1 activates med-1 in embryos lacking skn-1. (A–E) Wild-type and rict-1(mg451) mutants carrying the integrated marker wIs93[med-1::GFP] were fed with
control(RNAi) or skn-1(RNAi) as indicated. Paired DIC (left) and ﬂuorescence images (right). Scale bar represents 20 μm. (A) med-1::GFP expression in wild-type embryos. (B)
skn-1(RNAi) embryos arrest development and completely lack med-1::GFP expression. (C) In rict-1(mg451) mutants med-1::GFP expression is similar to wild-type.
(D) Embryos grown on rict-1(mg451);skn-1(RNAi) show an increasedmed-1::GFP expression. (E) Quantiﬁcation ofmed-1::GFP positive embryos from A–D. Substantially more
rict-1 mutants fed with skn-1(RNAi) display med-1::GFP positive cells compared to skn-1(RNAi) embryos. Mann–Whitney rank sum test. po0.05. Error bars, SEM. n, number
of embryos scored.
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for degradation (Choe et al., 2009; Hasegawa and Miwa, 2010).
Accordingly, loss ofwdr-23 increased SKN-1 protein levels and activity.
Here, we tested whether knockdown of wdr-23 affects rict-1;skn-1
embryonic viability. However, wdr-23(RNAi) did not alter the fraction
of viable rict-1;skn-1 embryos (Table 4). This suggests that wdr-23
might not inﬂuence SKN-1 activity in the embryo, or that increased
levels of embryonic SKN-1 per se are not sufﬁcient to enhance rescue
of the embryonic skn-1 phenotype.
To address further whether residual SKN-1 might be required for
TORC2 embryonic functions, we tested the effect of a skn-1 allele
that is predicted to be null: tm3411 bears a deletion that should
essentially destroy the DNA binding capacity of SKN-1 (Blackwell
et al., 1994) (Supplementary Fig. S1). Interestingly, we still observed
2.4% viable embryos in rict-1(mg451);skn-1(tm3411), while all
embryos of skn-1(tm3411) underwent developmental arrest and
died (Table 4). This result suggests that the increased viability of
rict-1;skn-1 mutants might not be solely the consequence of
residual SKN-1 activity, and argues towards involvement of an
alternative downstream process that works together with SKN-1.
Following the hypothesis that rict-1 could exert its functions
independently of skn-1 and modulate another factor we consid-
ered the possibility that this might involve SKNR-1, a protein that
is closely related to SKN-1 but so far has no known function
(Blackwell et al., 1994; Bowerman et al., 1992) (Supplementary Fig.
S1). To assess if sknr-1 can compensate for loss of skn-1 function and
account for viability in rict-1;skn-1 embryos we created rict-1;skn-1;
sknr-1 triple mutants. We found that mutation of sknr-1 did not
affect rict-1;skn-1 viability: there was no difference in the fraction of
survivors between rict-1(mg451);skn-1(zu135) mutants and rict-1;
skn-1;sknr-1(tm2386) (Table 4). sknr-1 mutants displayed no
obvious defects in development. We also tested a different sknr-1
allele, ok1216. Again, sknr-1(ok1216) did not change the viability of
rict-1;skn-1 mutant embryos (Table 4). These observations indicate
that sknr-1 does not contribute to the rescue of embryonic lethality
by rict-1. Together, the data suggest that the embryonic functions of
RICT-1/TORC2 involve SGK-1 and SKN-1, but also that RICT-1/TORC2
might regulate an alternative, as yet undeﬁned process that acts in
parallel to SKN-1 in the embryo.
Discussion
We have identiﬁed rict-1/CeRictor as a new regulator of
embryonic development in C. elegans. Our ﬁndings revealed that
mutation of rict-1 re-established mesendodermal speciﬁcation in
skn-1 deﬁcient worms, and thereby suppressed skn-1-associated
lethality. Moreover, inactivation of let-363/CeTOR, lst-8, and sinh-1,
but not rheb-1 and daf-15/Raptor partially rescued skn-1 embryo-
nic lethality. Thus, TORC2 but not TORC1 antagonizes skn-1 during
embryonic development. Importantly, sgk-1 mediated these func-
tions downstream of rict-1/TORC2 as the rict-1 mutant phenotype
was phenocopied by loss of sgk-1 function, and suppressed by a
sgk-1 gain-of-function mutant.
Inactivation of rict-1/TORC2 promotes skn-1 developmental processes
rict-1 deﬁcient worms display pleiotropic phenotypes, including
reduced growth and body size, metabolic changes of the fat content,
Table 4
sknr-1 cannot compensate for loss of skn-1 function. Strains were fed with RNAi or OP50 as indicated and the fraction of embryos that survived beyond L1 was counted.
Strain n
(Adult worms)
Mean number
of Eggs7SEM
% Survival 7SEM P value versus
control
rict-1(mg451);skn-1(zu135);sknr-1(tm2386) OP50 14 14274 2.070.3 nsa, o0.001b
rict-1(mg451);skn-1(zu135) OP50 10 14179 2.270.1 o0.001b
skn-1(zu135);sknr-1(tm2386) OP50 10 26975 0
skn-1(zu135) OP50 10 304714 0
sknr-1(tm2386) OP50 8 233713 100
rict-1(mg451);skn-1(zu67);sknr-1(ok1216) OP50 26 103712 4.270.5 nsc, o0.001d
rict-1(mg451);skn-1(zu67) OP50 26 95719 4.570.5 o0.001d
skn-1(zu67);sknr-1(ok1216) OP50 26 206714 0
skn-1(zu67) OP50 27 211714 0
sknr-1(ok1216) OP50 5 254 716 100
skn-1(tm3411) HT115 5 200714 0
rict-1(mg451);skn-1(tm3411) HT115 10 13976 2.470.1 o0.001g
Strain RNAi n
(Adult worms)
Mean number
of Eggs7SEM
% Survival7SEM P value versus
control
N2 skn-1 20 24079 0.570.1
rict-1(mg451) skn-1 19 11374 14.571.3 o0.001e
rict-1(mg451);skn-1(zu67) control 27 13376 5.270.4 o0.001e
rict-1(mg451);skn-1(zu67) skn-1 27 11276 2.870.2 o0.01f,o0.01e
skn-1(zu67) control 15 21876 0
skn-1(zu67) wdr-23 20 17378 0.1 nsh
rict-1(mg451);skn-1(zu67) control 20 10975 4.670.5 o0.001h
rict-1(mg451);skn-1(zu67) wdr-23 20 10674 4.070.3 nsi, o0.001h
ns, not signiﬁcant.
a p value was calculated versus rict-1(mg451);skn-1(zu135).
b p value was calculated versus skn-1(zu135).
c p value was calculated versus rict-1(mg451);skn-1(zu67).
d p value was calculated versus skn-1(zu67).
e p value was calculated versus N2 on skn-1(RNAi).
f p value was calculated versus rict-1(mg451);skn-1(zu67);control(RNAi).
g p value was calculated versus skn-1(tm3411).
h p value was calculated versus skn-1(zu67);control(RNAi).
i p value was calculated versus rict-1(mg451);skn-1(zu67);control(RNAi).
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and increased lifespan compared to wild-type (Jones et al., 2009;
Robida-Stubbs et al., 2012; Soukas et al., 2009). Our previous
analyses suggested that TORC2 opposed skn-1 to regulate aging
(Robida-Stubbs et al., 2012). We now describe a function of rict-1/
TORC2 in skn-1 dependent developmental processes. skn-1 mutant
embryos lack mesodermal tissue, and most but not all embryos also
fail to specify endoderm (Bowerman et al., 1992; Maduro et al.,
2007; our own data). While essentially all skn-1 deﬁcient embryos
are dead, loss of rict-1 restored viability to a small but reproducibly
detectable fraction of the embryos. We observed that a fraction of
rict-1;skn-1-deﬁcient embryos generated a complete pharynx and
intestine (based upon morphology and staining of ceh-22 and elt-2).
Furthermore, expression of med-1, which is a direct target of skn-1
and correlates with skn-1 function (Maduro et al., 2001, 2007), was
induced by rict-1 deﬁciency indicating activation of the canonical
SKN-1 network for mesendodermal speciﬁcation by EMS. Interest-
ingly, inactivation of rict-1 restored not only formation of the
posterior, MS-derived portion of the pharynx but also of the
anterior pharynx in skn-1 deﬁcient embryos. The anterior portion
of the pharynx is speciﬁed by cell-cell interaction between MS and
ABa descendants (Fig. 3A). A skn-1 dependent signal is expressed in
the MS cell that triggers anterior pharynx development in ABa. The
identity of this factor remains unknown, though it is likely to be a
DSL (Delta/Serrate/Lag) family ligand that induces anterior pharynx
development through the GLP-1/Notch receptor (Bowerman et al.,
1992; Mango et al., 1994; Priess et al., 1987). Thus, at least two
distinct SKN-1 targets are restored to their correct spatiotemporal
expression in rict-1 mutant embryos: med-1/2 assigning mesendo-
dermal speciﬁcation as well as Delta-like factor signaling from MS
to ABa.
Our data suggest that genetic interference with rict-1/TORC2
might release skn-1 function from inhibition, and promote devel-
opmental processes. Consistent with the hypothesis that rict-1
inactivation enhances SKN-1 activity, knockdown of residual skn-1
functions by RNAi in rict-1(mg451);skn-1(zu67) mutants signiﬁ-
cantly abolished embryonic viability, albeit the effect was not
complete. Of note, the skn-1 alleles zu67 and zu135 show incom-
plete penetrance of the mesendodermal differentiation phenotype
and may represent strong loss-of-function rather than true null
alleles (Bowerman et al., 1992; Raj et al., 2010). One might
speculate that TORC2-SGK-1 directly inﬂuences SKN-1 activity at
several levels, from transcription to protein degradation and
posttranslational modiﬁcations. However, we observed that skn-1
mRNA levels were not affected by rict-1 and sgk-1, suggesting that
TORC2-SGK-1 does not simply inﬂuence skn-1 expression. Notably,
it was shown in previous studies that SKN-1 activity is regulated
through phosphorylation in adult worms. SGK-1 and AKT-1/2
phosphorylated SKN-1, and repressed its nuclear accumulation
and activation (Tullet et al., 2008). Alternatively the interaction
could be more indirect, if both SKN-1 and TORC2 impinge on
common processes. In agreement with this hypothesis, we
observed that double knockout of rict-1(mg451) and skn-1
(tm3411) predicted null mutants still resulted in a fraction of
viable embryos. This result argues towards an alternative factor
involved in mesendodermal development. TORC2 might provide a
permissive environment for the speciﬁcation of mesendoderm fate
by SKN-1 and possibly other factors. Further work is needed to
identify these factors and determine their functions in TORC2-
signaling.
Of note, previous studies indicated that the TOR kinase let-363
and ruvb-1, an AAAþATPase homolog, can suppress pha-4 asso-
ciated lethality. Mutation of let-363/TOR and ruvb-1 restored
pharynx development in a hypomorphic pha-4 strain, suggesting
that TOR antagonizes pha-4 (Sheaffer et al., 2008; Updike and
Mango, 2007). Whether this is primarily a TORC1 effect or also
involves TORC2 is so far unknown. The transcription factor PHA-4
has an essential role in the embryonic development of the
pharynx, but also acts later in life to regulate growth and longevity
(Gaudet and Mango, 2002; Panowski et al., 2007). Here, we have
described TORC2-mediated suppression of a more upstream com-
ponent in the early EMS lineage. A speculative possibility is that
there might be a common mechanism in which TORC2-mediated
de-repression of a SKN-1 like activity increases pha-4 expression,
thereby allowing pharynx development.
TORC2 but not TORC1 suppresses skn-1 associated embryonic
lethality
We observed that inactivation of the TORC2 core components
rict-1, let-363/TOR, lst-8, and sinh-1 rescued skn-1 embryonic
lethality. Of note, LST-8 is part of both complexes, TORC1 and
TORC2. Yet, previous studies have demonstrated that Lst8 func-
tions exclusively in TORC2 and that mutation of Lst8 recapitulated
the rictor knockout phenotype in mice, ﬂies, and C. elegans
(Guertin et al., 2006; Jones et al., 2009; Wang et al., 2012).
Interestingly, genetic inhibition of the TOR kinase let-363 only
had a mild effect on skn-1 associated lethality. LET-363 is part of
both complexes, making it difﬁcult to distinguish individual
functions. However, our genetic analyses indicate that TORC1
appears not to be involved in control of early embryonic develop-
ment. As very strong inhibition causes defects in larval develop-
mental which might confound embryonic functions (Honjoh et al.,
2009; Jia et al., 2004), we tested different genetic manipulations
(RNAi and mutations) to gradually reduce TORC1 functions. We
show that knockdown of the TORC1 speciﬁc genes daf-15/Raptor
and rheb-1 did not promote skn-1 viability. Taken together, our
data show that TORC2 but not TORC1 regulates skn-1-dependent
developmental processes.
SGK-1 functions downstream of TORC2 to modulate skn-1 activity
Our results indicate that TORC2 and SGK-1 participate in a
pathway that regulates embryonic development. In rescuing skn-1
embryonic lethality, inactivation of sgk-1 phenocopied inactivation
of TORC2 components, and rict-1;sgk-1 double mutants showed no
additive effect compared to single mutants. Additionally, a con-
stitutive active sgk-1 mutant (Jones et al., 2009) suppressed the
rict-1 embryonic phenotype, consistent with positioning sgk-1
downstream of rict-1/TORC2 in a common pathway.
TORC2 is believed to control cell survival and growth by phosphor-
ylating several AGC kinases, including AKT and SGK. Emerging data
emphasize the function of SGK-1 as an important downstream effector
of TORC2. TORC2 signals predominantly through SGK-1 to regulate
growth, fat metabolism, and reproduction, while AKT seems only be
partially involved downstream of TORC2 under certain conditions in C.
elegans (Jones et al., 2009; Soukas et al., 2009). In yeast, activation of
the SGK homolog YPK2 required phosphorylation by TORC2, and
seemed to mediate most of TORC2 functions (Aronova et al., 2008;
Kamada et al., 2005; Niles et al., 2012). Similarly, in mammals it has
been shown that TORC2 phosphorylates and activates SGK1 (Garcia-
Martinez and Alessi, 2008). The physiological signiﬁcance of this
mTORC2-SGK interaction however is just beginning to be revealed.
Our data support the hypothesis that SGK rather than AKT is a critical
output of TORC2 in regulating growth and development in C. elegans.
Together, our data show that TORC2-SGK-1 signaling antago-
nizes SKN-1 to control mesendodermal embryonic development. It
is particularly surprising that TORC2 inﬂuences SKN-1 in the
context of both embryonic development and aging. TORC2 is
involved in growth and metabolism (Cybulski and Hall, 2009;
Jones et al., 2009; Robida-Stubbs et al., 2012; Soukas et al., 2009),
and SKN-1 functions include response to environmental stres
sors, regulation of development and cellular homeostasis
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(Bowerman et al., 1992; Wang et al., 2010). Perhaps under certain
conditions it might be advantageous to mobilize these mechan-
isms regulated by SKN-1.
Experimental procedures
C. elegans growth conditions
C. elegans were raised at 20 1C on standard nematode growth
media plates seeded with Escherichia coli OP50 as described
(Brenner, 1974).
Strains used in this study
The following strains were used in this study: N2 Bristol (wild-
type), NL2099 rrf-3(pk1426), ENH190 rict-1(mg451) (gift from A.
Soukas & G. Ruvkun, outcrossed 4 times), KQ1366 rict-1(ft7),
BR4774 sgk-1(ok538), ENH261 rict-1(mg451);sgk-1(ok538), KQ1564
sgk-1(ft15), ENH337 rict-1(mg451);sgk-1(ft15), EU1 skn-1(zu67)/
nT1[unc-?(n754);let-?], ENH177 rict-1(mg451);skn-1(zu67)/nT1[unc-?
(n754);let-?], ENH226 skn-1(zu67)/nT1[unc-?(n754);let-?];sgk-1(ok538),
ENH256 rict-1(ft7);sgk-1(ft15), EU31 skn-1(zu135)/nT1[unc-?(n754);let-
?], ENH197 rict-1(mg451);skn-1(zu135)/nT1[unc-?(n754);let-?], DR2381
let-363(h111)/dpy-5(e61), DR412 daf-15(m81)/unc-24(e138), RB759 akt-
1 (ok525), VC204 akt-2(ok393), ENH200 skn-1(tm3411)/nT1[unc-?
(n754);let-?] (outcrossed 4x), ENH224 rict-1(mg451);skn-1(tm3411)/
nT1[unc-?(n754);let-?], ENH284 sknr-1(tm2386) (outcrossed 4x),
ENH297 rict-1(mg451);sknr-1(tm2386), ENH298 skn-1(zu135)/nT1[unc
-?(n754);let-?];sknr-1(tm2386), ENH299 rict-1(mg451);skn-1(zu135)/
nT1[unc-?(n754);let-?];sknr-1(tm2386). LD1151 sknr-1(ok1216) (4x out-
crossed), ENH269 rict-1(mg451);sknr-1(ok1216), ENH278 skn-1(zu67)/
nT1[qIs51];sknr-1(ok1216), ENH279 rict-1(mg451);skn-1(zu67)/nT1
[qIs51];sknr-1(ok1216). JR1130 wIs84[elt-2::NLS::GFP::lacZ,rol-6D], MS94
cuIs1(ceh-22::GFP;rol-6), MS730 wIs93[med-1::GFP::MED-1]. Integrated
GFP reporters for elt-2, ceh-22, and med-1 were obtained from M.
Maduro. ENH271 rict-1(mg451);wIs84[elt-2::NLS::GFP::lacZ rol-6D],
ENH272 rict-1(mg451);cuIs1(ceh-22::GFP;rol-6), ENH273 rict-1
(mg451);wIs93[med-1::GFP::MED-1].
Double mutants rict-1;skn-1 and skn-1;sgk-1 were created by
mating male rict-1 or sgk-1 homozygous with skn-1/nT1[unc-?
(n754);let-?] heterozygous hermaphrodites that have an Unc phe-
notype. After transgenic males were successfully crossed twice with
skn-1/nT1 hermaphrodites F3 Unc progeny was selected for main-
tenance. Similarly, triple mutants rict-1;skn-1;sknr-1 were created
by mating rict-1;sknr-1 males with skn-1/nT1[unc-?(n754);let-?]. All
mutations were conﬁrmed by PCR and sequencing.
RNA interference
RNAi by bacterial feeding was performed as described (Kamath
et al., 2001). HT115 bacteria expressing the appropriate construct
or pPD129.36 as empty vector control were grown in overnight
cultures containing 12.5 mg/ml tetracycline and 50 mg/ml ampicil-
lin. On the following day, cultures were diluted, grown to an
OD600 of 1, and induced with 1 mM IPTG. This culture was seeded
onto NGM plates containing 1 mM IPTG, ampicillin and tetracy-
cline. For simultaneous knockdown of skn-1 and TOR complex
components RNAi cultures were mixed 1:1. The rrf-3(pk1426) RNAi
supersensitive strain was used to enhance the effectiveness of
targeting multiple genes.
RNAi clones for rict-1, sgk-1, rheb-1, sinh-1, and wdr-23 were
derived from the ORF-RNAi library v1.1. skn-1was obtained from K.
Blackwell (Tullet et al., 2008), let-363 was previously described
(Vellai et al., 2003). For lst-8 and daf-15 RNAi partial cDNA was
cloned into pPD129.36. All clones were conﬁrmed by sequencing.
Brood size and larval survival
Hermaphrodites were allowed to lay eggs for 4–6 h on OP50 or
RNAi, and progeny were grown to the L4 stage. To assess the brood
size and viable offspring, individual L4 larvae were then placed
onto fresh NGM or RNAi plates. Worms were transferred every
other day onto new NGM or RNAi plates until egg-laying ceased.
The total number of progeny and viable offspring of each animal
were counted one to three days after removal of the parental
generation. All experiments were performed at 20 1C.
For experiments with skn-1 mutants, heterozygous skn-1 her-
maphrodites bearing the nT1 balancer and showing Unc pheno-
type were allowed to lay eggs. Homozygous F1 non-Unc skn-1 L4
larvae were then used for analysis of the brood size and embryonic
viability. The zu67 and zu135 alleles behave as strict maternal-
effect lethal mutations, all progeny produced by self-fertilization
of homozygous hermaphodites arrested during embryogenesis
(Bowerman et al., 1992).
Microscopy and immunoﬂuorescence
For analysis of mesodermal and endodermal development ceh-
22::GFP (Okkema and Fire, 1994), med-1::GFP (Maduro et al.,
2001), and elt-2::GFP (Fukushige et al., 1998) transgenic worms
were fed with skn-1(RNAi) or control(RNAi) starting from L1.
Embryos were collected from adult hermaphrodites, transferred
to an agar pad with M9 buffer and allowed to develop for an
interval of time equivalent to normal embryogenesis at 20 1C.
Light microscopy was performed using a Zeiss Axioplan
2-microscope equipped with Nomarski differential interference
contrast (DIC), an AxioCam-camera and the AxioVision-Software
Rel.4.8. GFP was detected using appropriate EGFP-ﬁlter sets (480/
20-nm excitation, 510/20-nm emission). Images were processed
with Adobe Photoshop Version 12.0. and ﬁgures compiled with
Adobe Illustrator CS5.
RNA isolation and quantitative PCR
For RNA preparation 300–500 young adult worms were picked
to a clean NGM plate to minimize bacterial contamination and
washed several times with M9 buffer. Total RNA extraction was
performed with Trizol (Sigma) followed by puriﬁcation with RNA
Clean & Concentrator (Zymo Research) and DNAse treatment
(Quiagen). The total concentration and purity of RNA was deter-
mined by absorbance at 260/280 nm (NanoDrop spectrophot-
ometer). cDNA synthesis was performed with 250 ng RNA using
Superscript III Kit (Invitrogen).
Quantitative PCR reactions were performed with qPCR Master-
Mix Plus w/o UNG for SYBRs Assay ROX (Eurogentec) and the
following primers: skn-1_for gaagttgtaccaaacgatgtgttcc and skn-
1_rev tgctgttgacgtcctgaagatcca. Y45F10D.4_for gtcgcttcaatcagttcagc
and Y45F10D.4_rev gttcttgtcaagtgatccgaca. cdc-42_for ctgctggacag-
gaagattacg and cdc-42_rev ctcggacattctcgaatgaag. Experiments
were performed in duplicates and carried out using Roche Light-
Cycler 480. The threshold cycle (Ct) values of the target genes
were analyzed and normalized to the reference genes Y45F10D.4
and cdc-42 (Hoogewijs et al., 2008). Relative skn-1 expression of
mutant strains was compared to wild-type using the 2ΔΔCt
method.
Statistical methods
Statistical analyses were carried out with SigmaStat 3.5. Com-
paring more than two groups, statistical analysis was performed
with non-parametric Kruskal–Wallis one-way analysis of variance.
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Non-parametric Mann–Whitney (also called Wilcoxon rank-sum)
test was used for pair-wise comparisons.
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